N Manjunath

Author PubWeight™ 77.73‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 2003 7.56
2 miRNA profiling of naïve, effector and memory CD8 T cells. PLoS One 2007 5.43
3 Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007 5.21
4 T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 2008 4.32
5 Migratory properties of naive, effector, and memory CD8(+) T cells. J Exp Med 2001 4.17
6 Rapid diagnosis of tuberculous meningitis by polymerase chain reaction. Lancet 1991 2.77
7 Identification of Mycobacterium tuberculosis by polymerase chain reaction. Lancet 1990 2.39
8 Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages. J Virol 2003 2.26
9 Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 2001 2.13
10 CD70+ antigen-presenting cells control the proliferation and differentiation of T cells in the intestinal mucosa. Nat Immunol 2005 2.02
11 CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood 2001 1.74
12 Alternative processing of primary microRNA transcripts by Drosha generates 5' end variation of mature microRNA. PLoS One 2009 1.63
13 A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med 2006 1.55
14 RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice. Mol Ther 2009 1.55
15 Dynamic regulation of T cell immunity by CD43. J Immunol 2002 1.45
16 Migration and differentiation of CD8+ T cells. Immunol Rev 2002 1.41
17 TCR signaling induces selective exclusion of CD43 from the T cell-antigen-presenting cell contact site. J Immunol 1998 1.37
18 Negative regulation of T cell homing by CD43. Immunity 1998 1.36
19 Targeted delivery of siRNA to macrophages for anti-inflammatory treatment. Mol Ther 2010 1.28
20 The prospect of silencing disease using RNA interference. JAMA 2005 1.24
21 Cutting Edge: Distinct NK receptor profiles are imprinted on CD8 T cells in the mucosa and periphery during the same antigen challenge: role of tissue-specific factors. J Immunol 2007 1.12
22 Impaired immune response to vaccinia virus inoculated at the site of cutaneous allergic inflammation. J Allergy Clin Immunol 2007 1.05
23 A macrophage invasion mechanism for mycobacteria implicating the extracellular domain of CD43. J Exp Med 2000 1.05
24 Strategies for targeted nonviral delivery of siRNAs in vivo. Trends Mol Med 2009 1.04
25 P-body components LSM1, GW182, DDX3, DDX6 and XRN1 are recruited to WNV replication sites and positively regulate viral replication. Virology 2012 1.02
26 Concurrent generation of effector and central memory CD8 T cells during vaccinia virus infection. PLoS One 2008 0.98
27 Association of indoor air pollution with acute lower respiratory tract infections in children under 5 years of age. Paediatr Int Child Health 2012 0.94
28 Human macrophage and dendritic cell-specific silencing of high-mobility group protein B1 ameliorates sepsis in a humanized mouse model. Proc Natl Acad Sci U S A 2012 0.94
29 Isolation of Enterovirus 70 during conjunctivitis epidemic in Delhi in 1981. Indian J Med Res 1982 0.93
30 Avoiding the kiss of death: how HIV and other chronic viruses survive. Curr Opin Immunol 2002 0.93
31 The gp49B1 inhibitory receptor regulates the IFN-gamma responses of T cells and NK cells. J Immunol 2003 0.92
32 Blocking CD27-CD70 costimulatory pathway suppresses experimental colitis. J Immunol 2009 0.91
33 Rubella infection: the Indian scene. Rev Infect Dis 1985 0.91
34 Regulation of in vitro and in vivo T cell activation by CD43. Int Immunol 1998 0.90
35 Improved siRNA/shRNA functionality by mismatched duplex. PLoS One 2011 0.89
36 Silencing early viral replication in macrophages and dendritic cells effectively suppresses flavivirus encephalitis. PLoS One 2011 0.89
37 The Bcl-2 family pro-apoptotic molecule, BNIP3 regulates activation-induced cell death of effector cytotoxic T lymphocytes. Immunology 2003 0.88
38 Ago-2-mediated slicer activity is essential for anti-flaviviral efficacy of RNAi. PLoS One 2011 0.88
39 RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA? Expert Opin Biol Ther 2010 0.87
40 CD43 diminishes susceptibility to T lymphocyte-mediated cytolysis. J Immunol 1995 0.86
41 Long-term engraftment of human natural T regulatory cells in NOD/SCID IL2rγc(null) mice by expression of human IL-2. PLoS One 2012 0.84
42 Single amino acid change in gp41 region of HIV-1 alters bystander apoptosis and CD4 decline in humanized mice. Virol J 2011 0.82
43 Correlates of acute lower respiratory tract infections in children under 5 years of age in India. Int J Tuberc Lung Dis 2013 0.82
44 Silencing TNF-α in macrophages and dendritic cells for arthritis treatment. Scand J Rheumatol 2013 0.80
45 Anaesthetic management of closed mitral valvotomy for severe mitral stenosis with traumatic kyphoscoliosis. Indian J Anaesth 2010 0.79
46 Targeting the HIV entry, assembly and release pathways for anti-HIV gene therapy. Virology 2011 0.78
47 Serological study on congenital rubella in Delhi. Indian J Med Res 1984 0.77
48 A cytotoxic substance produced by a wild culture of Lactobacillus casei D-34 against tumour cells. Indian J Exp Biol 1989 0.77
49 Targeting DNA vaccines to myeloid cells using a small peptide. Eur J Immunol 2014 0.76
50 Study of an outbreak of epidemic conjunctivitis in Delhi in 1986. Indian J Pathol Microbiol 1989 0.75
51 Complement fixing antibodies in patients of suspected subacute sclerosing panencephalitis in Delhi. Indian J Med Res 1984 0.75
52 Detection of herpes simplex virus type 2 DNA in uterine cervix lesions using cloned Bgl II N fragment of HSV-2 DNA as a probe. Indian J Med Res 1988 0.75
53 Serologic survey for neutralizing antibodies against group B coxsackieviruses in normal population in Delhi area. Indian J Med Res 1982 0.75
54 Production of monoclonal antibodies to herpes simplex virus type 1 by hybridoma technique. Indian J Med Res 1985 0.75
55 Correlation of histologic types of carcinoma of the uterine cervix and human papillomavirus and herpes simplex virus type 2 DNA sequences in the uterine cervical biopsies. Arch Virol 1988 0.75
56 MicroRNA cloning from cells of the immune system. Methods Mol Biol 2010 0.75
57 Human papillomavirus & herpes simplex virus type 2 DNA sequences with chronic cervicitis & invasive cervical cancer. Indian J Med Res 1988 0.75
58 Cytotoxic activity of lactobacilli isolated from plant and dairy sources. Indian J Exp Biol 1989 0.75